Nokilaj Tissin

Fraunhofer Institute for Production Technology IPT

Papers

1

Total Citations

17

H-Index

1

About

Nokilaj Tissin is at the forefront of advancing cell therapy manufacturing through robotic automation, a critical area in the translation of advanced therapeutic medicinal products (ATMPs) from bench to bedside. His work directly addresses the bottleneck of producing high-quality, clinically-compliant cells at scale, replacing costly, high-risk manual processes. His most-cited paper, "Needle to needle robot-assisted manufacture of cell therapy products" (2022, 17 citations), introduces a fully integrated robotic system that automates the entire cell therapy workflow—from raw material to final product—ensuring Good Manufacturing Practice (GMP) compliance. This contribution is pivotal for making life-saving cell therapies more accessible and affordable. Tissin’s research is not only technically innovative but also practically impactful, offering a scalable solution to a pressing manufacturing challenge. His work is essential reading for students and researchers interested in the intersection of robotics, bioprocessing, and regenerative medicine, positioning him as a key figure in the industrialization of cell-based therapeutics.

Research Focus

Key Achievements

1
H-Index
1
Papers
17
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
Needle to needle <scp>robot‐assisted</scp> manufacture of cell therapy products
17 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Fraunhofer Institute for Production Technology IPT

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago